4Donahue G, Munoz A, Ness P M, et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med, 1992,327:364-373.
5Lombardi M, Cerrai T, Geatti S, et al. Results of a national epidemiological investigation of HCV infection in dialysis patients. EDTNA ERCA J, 1999,XXV(3):38-42.
6Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Perspectives in clinical hepatology, 2002,36:3-10.
7Centers for Disease Control and prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. Morb Mort Weekly Rep, 2001,50(RR-5):1-43.
8Fabrizi F, Martin P, Lunghi G, et al. Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: clinical perspectives. Int J Artif Organs, 2000,23:805-816.
9World Health Organization. Hepatitis C: global prevalence.Weekly Epidemiol Rec, 1997,(46):341-348.
10Hinrichsen H, Leimenstoll G, stegen G, et al. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: a multicentre study in 2796 patients. Liver disease Gul, 2002,51:429-433.
3Jing Yuan,Yi Yang, Fei Han, Ping Zhang, Xiao-Ying Du, Hua Jiang and Jiang-Hua Chen The Kidney Disease Center, First Affiliated Hospital, Zhejiang University School of Medicine (Yuan J, Yang Y, Han F, Zhang P, Du XY, Jiang H and Chen JH),and Hemodialysis Quality Control Center of Zhejiang Province (Yuan J, Zhang P, Du XY and Chen JH), Hangzhou 310003, China.Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus[J].Hepatobiliary & Pancreatic Diseases International,2012,11(3):302-306. 被引量：2
